MUMBAI, India, July 25 -- Intellectual Property India has published a patent application (202517065119 A) filed by Encoded Therapeutics, Inc., San Francisco, on July 8, for 'aav formulation.'
Inventor(s) include Wise, Nathan; Lamichhane, Aashish; Tran, Travis; and Moorhead, Martin.
The application for the patent was published on July 25, under issue no. 30/2025.
According to the abstract released by the Intellectual Property India: "The disclosure provides a composition comprising recombinant adeno-associated virus (AAV) vectors comprising a heterologous nucleic acid, sodium chloride, potassium chloride, magnesium chloride, phosphate buffer, and a non-ionic surfactant, at pH of 7.2-7.4. The disclosure further provides a method of treatin...